William C. Wood Research Symposium
The Annual William C. Wood Research Symposium showcases the basic and clinical science research of the Emory Department of Surgery's students, residents, and fellows, and features a keynote speaker of national prominence.
The 17th installment of the symposium will be held on Thursday, April 26, 2018, from 7:00 a.m.–11:00 a.m. in the Emory University Hospital Auditorium. The keynote address will be presented by Elizabeth A. Mittendorf, MD, PhD, associate professor in the Department of Breast Surgical Oncology at the University of Texas MD Anderson Cancer Center, after which the oral and poster presentations will proceed.
At the close of the symposium, cash awards will be given for the best oral presentations and posters in both clinical science and basic science categories. All winners will be invited to attend lunch with Dr. Mittendorf and Emory Surgery faculty members immediately thereafter.
The symposium's abstract call in both basic and clinical science categories has begun, and the submission deadline is Friday, December 15, 2017. Trainees in dedicated laboratory rotations are expected to submit their research, though the call is open to all trainees. Submissions are reviewed by a panel of the Department of Surgery Research Advisory Committee (SRAC), and considered for both oral and poster presentation.
William Wood: Renaissance Surgeon
William C. Wood
The symposium is named in honor of William Wood, MD, former chair of the Emory Department of Surgery from 1991-2009. Dr. Wood guided the department to becoming one of the nation's leading institutions for surgical research and innovation.
When Dr. Wood came to Emory from Massachusetts General Hospital, where he served as both medical director of the cancer center and chief of surgical oncology, the department had no NIH grants. By the time he stepped down from the chair's office, however, Emory Surgery had begun regularly placing in the upper ranks of academic departments of surgery receiving NIH funding.
Dr. Wood is also known for his outstanding contributions to cancer therapy—most specifically breast cancer treatment—and the design and meta-analysis of conceptually driven clinical trials.